Cingulate Inc. Reports Second Quarter 2023 Financial Results and Provides Clinical and Business Update
August 14, 2023 16:15 ET
|
Cingulate Inc.
Werth Family Investment Associates Provides Additional Capital InvestmentPhase 3 Adult Efficacy and Safety Trial of CTx-1301 Data ReleasedCTx-1301 Phase 3 Pediatric and Adolescent Studies Underway ...
Incannex Healthcare June 2023 Quarterly Activities Report and Appendix 4C Cash Flow Statement
July 28, 2023 07:30 ET
|
Incannex Healthcare
MELBOURNE, Australia, July 28, 2023 (GLOBE NEWSWIRE) -- Clinical stage pharmaceutical development company, Incannex Healthcare Limited (ASX: IHL) (NASDAQ: IXHL), (‘Incannex’ or the ‘Company’), is...
MDbio – The Doctors BrandTM Publishes New Article About Artificial Intelligence in Healthcare
July 24, 2023 09:00 ET
|
MDbio Wellness
Beverly Hills, California, July 24, 2023 (GLOBE NEWSWIRE) -- MDbio – The Doctors BrandTM published a new article about artificial intelligence in healthcare and what the future of this industry...
North America Leads Global Online Therapy Services Market in 2022, Asia-Pacific to Witness Rapid Growth, According to New Report
July 21, 2023 05:43 ET
|
Research and Markets
Dublin, July 21, 2023 (GLOBE NEWSWIRE) -- The "Online Therapy Services Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. This comprehensive report provides...
The Future of Global Mental Health Management Research Report 2023: Complementing Prescription Therapies with AI/ML/VR for Better Outcomes to Become More Prominent
July 20, 2023 05:38 ET
|
Research and Markets
Dublin, July 20, 2023 (GLOBE NEWSWIRE) -- The "The Future of Mental Health Management" report has been added to ResearchAndMarkets.com's offering. This report identifies the challenges, drivers,...
Incannex Announces Intention to Redomicile to United States, List all Shares on Nasdaq
July 10, 2023 07:30 ET
|
Incannex Healthcare
Highlights: Incannex to redomicile to the United States via a Scheme of Arrangement pursuant to Australian lawA newly formed Delaware corporation (Incannex Healthcare Inc.) will become the ultimate...
Incannex Receives Ethics Approval for Bioequivalence/Bioavailability Clinical Trial for IHL-42X, the Company’s Proprietary Drug for Treatment of Obstructive Sleep Apnoea (‘OSA’)
July 06, 2023 08:42 ET
|
Incannex Healthcare
Highlights: Incannex has received approval from Bellberry Human Research Ethics Committee (‘HREC’) to commence the bioavailability/bioequivalence (‘BA/BE’) clinical trial to assess the...
Incannex Announces Participation at the H.C. Wainwright 4th Annual Neuropsychiatry Virtual Conference June 26, 2023
June 23, 2023 08:00 ET
|
Incannex Healthcare
MELBOURNE, Australia, June 23, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’) a pharmaceutical company developing medicinal cannabinoid...
Incannex Appoints Principal Investigators for IHL-42X Phase 2/3 Clinical Trial
June 16, 2023 08:00 ET
|
Incannex Healthcare
MELBOURNE, Australia, June 16, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’) a clinical-stage pharmaceutical company developing unique...
New Active Relaxation Product Empowers Pain Sufferers to Overcome Stress, Anxiety, and Sleepless Nights
June 15, 2023 10:00 ET
|
Avaria Health & Beauty Corp
TORONTO, June 15, 2023 (GLOBE NEWSWIRE) -- Canadians experiencing pain can now find solace in KaLaya's new, Vegan Blueberry Active Relaxation Gummies. These gummies are designed to alleviate stress,...